# OnCo record radiographic-progression-free-survival (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/radiographic-progression-free-survival/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "radiographic-progression-free-survival" ;
  schema:name "Radiographic progression-free survival (rPFS)"@en ;
  schema:alternateName "rPFS"@en, "radiographic progression free survival"@en, "radiologic progression-free survival"@en, "imaging-based progression-free survival"@en, "rPFS by PCWG"@en ;
  schema:description "In cancer that has already spread, this is the time until the scans show it getting worse, or the man dies. It deliberately ignores a rising PSA on its own, because in prostate cancer the PSA can rise for reasons that do not mean the treatment has stopped working."@en ;
  schema:url <https://onco.cc/terms/radiographic-progression-free-survival/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/jco.2007.12.4487>, <https://doi.org/10.1200/jco.2015.64.2702> ;
  onco:tag "gu", "prostate-glossary" ;
  onco:related <https://onco.cc/terms/metastasis-free-survival/>, <https://onco.cc/terms/psa50/>, <https://onco.cc/trials/vision/>, <https://onco.cc/trials/profound/>, <https://onco.cc/terms/hazard-ratio/>, <https://onco.cc/terms/bone-metastases/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/>, <https://onco.cc/cancers/prostate-mhspc/>, <https://onco.cc/cancers/prostate-nepc/> ;
  onco:sections <https://onco.cc/fronts/hormonal/>, <https://onco.cc/fronts/imaging/>, <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/psma-pet/>, <https://onco.cc/technologies/pet/> ;
  onco:terms <https://onco.cc/terms/metastasis-free-survival/>, <https://onco.cc/terms/psa50/>, <https://onco.cc/terms/psa/>, <https://onco.cc/terms/hazard-ratio/>, <https://onco.cc/terms/castration-resistance/>, <https://onco.cc/terms/bone-metastases/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-trial-design/>, <https://onco.cc/bottlenecks/b-regulatory-fragmentation/>, <https://onco.cc/bottlenecks/b-resistance/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-abiraterone-acetate-prostate-n-engl-j-med-2013/>, <https://onco.cc/key-papers/paper-fizazi-triton3-rucaparib-nejm-2023/>, <https://onco.cc/key-papers/paper-antonarakis-ar-v7-resistance-nejm-2014/> .